Published by Global Banking & Finance Review®
Posted on May 7, 2025
3 min readLast updated: January 24, 2026
Add as preferred source on GoogleEuropean shares dropped as investors assessed earnings and awaited the Fed's rate decision. Retail and healthcare stocks led the losses.
By Sukriti Gupta and Nikhil Sharma
(Reuters) -European shares ended lower on Wednesday, pausing after weeks of strong gains, while investors monitored a raft of corporate earnings ahead of the U.S. Federal Reserve's rate decision later in the day.
The pan-European STOXX 600 index closed 0.5% lower, while other regional indexes also ended their day in the red.
European retail stocks led sectoral losses with a 2% fall. Data showed a more-than-expected decline in eurozone retail sales on a month-on-month basis in March.
Healthcare shares fell 1.8%. Shares of drugmakers AstraZeneca, GSK and Sanofi fell between 1.8% and 4.3% after the U.S. FDA appointed on Tuesday agency critic Vinay Prasad as its top vaccine official.
European equities have recovered their sharp losses from early April, primarily because of several indications that U.S.-China trade tensions could de-escalate.
"They've (European indices) had a strong recovery from the April lows at the beginning of this week. So we're just having a little bit of breathing space," said Fiona Cincotta, senior market analyst at City Index.
U.S. Treasury Secretary Scott Bessent and chief trade negotiator Jamieson Greer will meet China's top economic official in Switzerland for talks this weekend. This could be the first step towards resolving a trade war ignited by U.S. President Donald Trump.
Meanwhile, focus will be on the Fed's interest rate decision later in the day. While traders expected the central bank to keep rates unchanged, they will look for comments on future policy moves.
"There is a little bit of nervousness ahead of the Federal Reserve interest rate decision later today, where potentially the Fed could adopt a more hawkish lean."
Separately, German conservative leader Friedrich Merz was elected chancellor by parliament in a second round of voting after an unprecedented defeat on a first attempt got his coalition government off to a wobbly start.
Mark Branson, the president of Germany's bank watchdog BaFin, said on Wednesday that the nation's financial firms were in a strong position but that uncertainty would remain extremely high.
Among individual stocks, Novo Nordisk was up 1.3% after it surpassed first-quarter profit estimates, though it cut its 2025 outlook.
Jyske Bank rose 7.1%, the best individual performer for the day, after the Danish lender posted strong first-quarter results.
Ambu slumped 13.5%, after the Danish medical equipment maker reported second-quarter sales and earnings below expectations.
Tomra tumbled 7.7% after the Norwegian provider of recycling and waste sorting solutions posted weaker-than-expected first-quarter earnings.
BMW rose 1.6% after the luxury carmaker posted better-than-expected first-quarter results and confirm its 2025 outlook.
(Reporting by Sukriti Gupta; Editing by Janane Venkatraman and Sonia Cheema)
The article discusses the decline in European shares as investors assess corporate earnings and await the Federal Reserve's rate decision.
Healthcare shares fell due to the appointment of Vinay Prasad as the U.S. FDA's top vaccine official, affecting major drugmakers.
The talks could potentially ease trade tensions, which have been impacting global markets, including European equities.
Explore more articles in the Finance category
